WebMay 12, 2024 · SAN DIEGO-- ( BUSINESS WIRE )-- Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early … WebFounded Date Jan 1, 2016. Founders Samuel Levy. Operating Status Closed. Last Funding Type Series C. Legal Name Bluestar Genomics, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number (833) 258-7827. Bluestar Genomics delivers epigenomic and big data approaches to reinvent non-invasive molecular …
Bluestar Genomics Advances to Commercial Phase, Rebrands as …
WebDec 21, 2024 · Bluestar Genomics today announced the company’s U.S. and international commercialization of its first test for early detection of pancreatic cancer in high-risk patients, and unveiled a new name, ClearNote Health™. ... This press release features multimedia. View the full release here: ... WebJun 15, 2024 · The case is 3:21-cv-04507, Bluestar Genomics v. Song et al. This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates … discard items in subnautica
Bluestar Genomics Receives FDA Breakthrough Device …
WebApr 13, 2024 · Forward-Looking Statements of Bionano Genomics. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “may,” “potential,” “will,” and similar expressions (as well as other words or expressions referencing future events ... WebOct 10, 2024 · Bluestar Genomics, Inc., an early cancer detection company leading the development and commercialization of next-generation liquid biopsy tests focused on non-invasive detection of high-mortality cancers in high-risk patient populations, today announced it received accreditation for its clinical laboratory from the College of … WebDec 21, 2024 · Bluestar Genomics Advances to Commercial Phase, Rebrands as ClearNote Health - ClearNote Health Our Story Our Approach Our Tests Test Ordering … founders pcb 2080ti water cooler